AU Stock MarketDetailed Quotes

CUV Clinuvel Pharmaceuticals Ltd

Watchlist
  • 15.120
  • -0.130-0.85%
20min DelayTrading Jul 23 13:24 AET
757.57MMarket Cap25.58P/E (Static)

Clinuvel Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Clinuvel Pharmaceuticals Ltd Earnings Date

Currency: AUD

Period

H1 FY2024 Earnings

Feb 22, 2024

Revenue(YoY)

32.26M

+9.89%
EPS(YoY)

0.21

-7.83%
Analyst Rating

Buy

Jul 16, 2024

Clinuvel Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 53.700M--
Feb 22, 20242024/H132.257M / 34.433M--
Aug 29, 20232023/H248.966M / 46.300M--
Aug 31, 20222022/H241.091M / 35.600M--
Aug 31, 20212021/H234.342M / 28.100M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 53.700M--
Feb 22, 20242024/H132.257M / 34.433M--
Aug 29, 20232023/H248.966M / 46.300M--
Aug 31, 20222022/H241.091M / 35.600M--
Aug 31, 20212021/H234.342M / 28.100M--

Unlock Free Earnings Estimates

Clinuvel Pharmaceuticals Ltd Earnings Reports

  • Clinuvel Pharmaceuticals Ltd: CLINUVEL Delivers Increased Revenues, Solid Earnings

    Feb 21 18:11 ET

  • Clinuvel Pharmaceuticals Ltd: CUV Appendix 4D Half Year Report

    Feb 21 17:48 ET

  • Clinuvel Pharmaceuticals Ltd: CLINUVEL delivering increases in annual revenue, profit

    Aug 28, 2023 20:36 ET

  • Clinuvel Pharmaceuticals Ltd: Appendix 4E and Annual Report to Shareholders 2023

    Aug 28, 2023 20:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 16, 2024

    Buy

    • Strong Buy

      71.43%

    • Buy

      0.00%

    • Hold

      28.57%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    %Chg